Raphas Co., Ltd. (KOSDAQ: 214260)

Market Cap	117.30B
Revenue (ttm)	27.46B
Net Income (ttm)	-4.34B
Shares Out	8.41M
EPS (ttm)	-501.25
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,719
Open	13,350
Previous Close	13,480
Day's Range	13,080 - 14,400
52-Week Range	9,300 - 31,500
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Raphas

Raphas Co., Ltd. provides skin-based drug delivery systems in South Korea, Japan, and China. The company offers cosmetics under the Acropass brand. It also provides original design manufacturer services in producing cosmetics for various needs, such as wrinkle reduction, freckle, and acne treatment; and medical contract manufacturing services. The company was founded in 2006 and is headquartered in Seoul, South Korea.

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2006
• Employees: 81
• Stock Exchange: KOSDAQ
• Ticker Symbol: 214260

Financial Performance

In 2023, Raphas's revenue was 27.94 billion, an increase of 18.18% compared to the previous year's 23.64 billion. Losses were -8.80 billion, 3.45% more than in 2022.